SCHEMBL3132765

SCHEMBL3132765

Cc1cccc([S+](c2ccccc2)c2ccccc2)c1.FC(F)(F)c1cc([B-](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
NFE2L2 Q16236 1/20 0.34
KCNK3 O14649 1/20 0.34
KCNK9 Q9NPC2 1/20 0.34
CETP P11597 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
KIF11 P52732 3/20 0.33
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
TACR1 P25103 1/20 0.32
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
AR P10275 1/20 0.31
GRIK1 P39086 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3139818 0.88 NFE2L2 (0.39) PTPN5HTTNFE2L2KIF11TSHR
SCHEMBL3132670 0.88 NFE2L2 (0.39) PTPN5HTTNFE2L2KIF11TSHR
SCHEMBL6513245 0.88 TSHR (0.41) MEN1HTTRAB9AKMT2AKIF11
SCHEMBL3244276 0.88 TSHR (0.41) MEN1HTTRAB9AKMT2AKIF11
SCHEMBL3139294 0.83 KIF11 (0.46) MEN1KMT2AKIF11TSHRALDH1A1
SCHEMBL3144568 0.83 KIF11 (0.46) MEN1KMT2AKIF11TSHRALDH1A1
SCHEMBL3136015 0.82 NPSR1 (0.41) MEN1RAB9AKMT2ARXFP1AR
SCHEMBL3130046 0.82 RAPGEF4 (0.38) NFE2L2RAPGEF4KIF11TSHRALDH1A1
SCHEMBL3130532 0.81 ACHE (0.39) RAB9ATSHRALDH1A1RXFP1CNR1
Toluene SCHEMBL6538388 0.81 TSHR (0.41) PTPN5NFE2L2RAPGEF4KIF11TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642368-B2 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-01-05 US disclosed
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2007-04-12 US disclosed
EP-1676835-A1 PROCESS FOR PRODUCING TRIARYLSULFONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2006-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid ARSA, HAO2, HAO1 PTPN5 344/4885MEN1 3088/4885HTT 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.